NEW YORK (GenomeWeb News) – Bruker Biosciences today reported that total revenues for the second quarter increased nearly 10 percent as net income jumped 69 percent.
The report caused shares in Bruker to trade up 6 percent, or $.35, at $5.86 in mid-afternoon trading.
Receipts for the three months ended June 30 increased to $78 million from $71 million year over year.
R&D costs declined 3 percent to $10.6 million from $11 million from the comparable quarter a year ago.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.